<img height="1" width="1" style="display:none;" alt="" src="https://px.ads.linkedin.com/collect/?pid=2653956&amp;fmt=gif">
Image Overlay - Enesi Pharma's ImplaVax® Solid-Dose and Needle-Free Vaccination Platform Wins Award at the World Vaccine Congress
Image Overlay - Enesi Pharma's ImplaVax® Solid-Dose and Needle-Free Vaccination Platform Wins Award at the World Vaccine Congress

Enesi Pharma's ImplaVax® Solid-Dose and Needle-Free Vaccination Platform Wins Award at the World Vaccine Congress

October 9, 2020

Enesi Pharma's ImplaVax® Solid-Dose and Needle-Free Vaccination Platform Wins Award at the World Vaccine Congress

Enesi Pharma, a biotechnology company developing next-generation vaccination products enabled by its ImplaVax® technologies, was awarded the 'Best New Vaccine Technology/Platform Award' at the World Vaccine Congress Washington Virtual annual event (28 September – 1 October 2020). Knowing the logitical challenges ahead in distributing COVID-19 vaccines, Yourway is paying close attention to such enabling technologies.

 Back to Index
Stay Connected

Want to stay informed about the latest news, updates, and opportunities at Yourway?

Join our newsletter mailing list to never miss an update!

Media

Upcoming Events

Pharma Supply Chain & Logistics Innovation Programme EU

May 20-21, 2026
Basel, Switzerland

Clinical Trial Supply West Coast

September 22-23, 2026
Burlingame, CA

Media

Articles

Global Reach in Clinical Trials: Beyond Presence to True Execution

Open chat
Come chat with us!
Hello! How can I help you?